Full Name
Yan, J.
Variants
Yan, J.
 
 
Email
csiyanj@nus.edu.sg
 

Publications

Results 1-7 of 7 (Search time: 0.005 seconds).

Issue DateTitleAuthor(s)
1Oct-2013Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemiaYan, J. ; Jiang, N.; Huang, G. ; Tay, J.L.-S.; Lin, B.; Bi, C.; Koh, G.S.; Li, Z.; Tan, J.; Chung, T.-H. ; Lu, Y.; Ariffin, H.; Kham, S.K.Y.; Yeoh, A.E.J.; Chng, W.-J.
23-Nov-2011Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphomaNg, S.-B.; Yan, J. ; Huang, G. ; Selvarajan, V.; Tay, J.L.-S.; Lin, B.; Bi, C.; Tan, J.; Kwong, Y.-L.; Shimizu, N.; Aozasa, K.; Chng, W.-J.
330-May-2013EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity.Yan, J. ; Ng, S.B.; Tay, J.L.; Lin, B.; Koh, T.L.; Tan, J.; Selvarajan, V.; Liu, S.C.; Bi, C.; Wang, S.; Choo, S.N.; Shimizu, N.; Huang, G.; Yu, Q.; Chng, W.J.
427-Jun-2013Genome-wide Kinase-Chromatin Interactions Reveal the Regulatory Network of ERK Signaling in Human Embryonic Stem CellsGöke, J.; Chan, Y.-S.; Yan, J. ; Vingron, M.; Ng, H.-H. 
52015Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myelomaBi, C; Chung, T.-H ; Huang, G ; Zhou, J ; Yan, J ; Ahmann, G.J; Fonseca, R; Chng, W.J 
62018LEE011 and ruxolitinib: A synergistic drug combination for natural killer/T-cell lymphoma (NKTCL)Hee, Y.T; Yan, J ; Nizetic, D; Chng, W.-J 
78-Jan-2019Towards understanding of PRC2 binding to RNAJunli Yan ; Bibek Dutta; Yan Ting Hee; Wee Joo Chng